Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by Vette81on Jun 20, 2018 11:16pm

80 Views

Post# 28203361

Have we forgotten June 6th

Theralase Demonstrates 36 Months Stability of Lead Anti-Cancer Drug Toronto, Ontario (FSCwire) - Theralase Technologies Inc. (Theralase or the Company) (TSXV: TLT) (OTCQX: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds (PDCs) and their associated drug formulations intended to safely and effectively destroy cancer has announced today that it has demonstrated 36 months long term stability of the clinical batch of its lead anti-cancer PDC, TLD-1433. Read more at https://www.stockhouse.com/news/press-releases/2018/06/06/theralase-demonstrates-36-months-stability-of-lead-anti-cancer-drug This was a really important piece of info for us that day.

Bullboard Posts

Eminent acquires promising Nevada gold project